Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR): Drug Safety Communication - Strengthened Kidney Warnings
Revised warnings in the drug labels to include information about acute kidney injury and added recommendations to minimize this risk.
Source: FDA MedWatch Safety Alert - Category: American Health Source Type: alerts
More News: American Health | Canagliflozin | Dapagliflozin | Forxiga | Invokana | Urology & Nephrology | Warnings